Citation Impact
Citing Papers
A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non–Small Cell Lung Cancer
2017
Nanoparticles: Properties, applications and toxicities
2017 Standout
Transcriptional Regulation by Nrf2
2017 Standout
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
2019 Standout
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
2015
WISP1 Predicts Clinical Prognosis and Is Associated With Tumor Purity, Immunocyte Infiltration, and Macrophage M2 Polarization in Pan-Cancer
2020
A view on drug resistance in cancer
2019 StandoutNature
Liposomes, a promising strategy for clinical application of platinum derivatives
2013
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Delivery materials for siRNA therapeutics
2013 Standout
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
2009
Delivery technologies for cancer immunotherapy
2019 Standout
Non-viral vectors for gene-based therapy
2014 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Progress in brain targeting drug delivery system by nasal route
2017
Drug delivery vehicles on a nano-engineering perspective
2014
Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs
2013
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
2020 Standout
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
2011
New Therapeutic Challenges in Advanced Bladder Cancer
2012
Cisplatin: The first metal based anticancer drug
2019 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Liposomes as nanomedical devices
2015 Standout
Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin
2016
Liposomal cisplatin: a new cisplatin formulation
2010
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Clinical usefulness of liposomal formulations in cancer therapy: lessons from the experiences of doxorubicin
2018
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Nanoparticle Delivery of Cancer Drugs
2011
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Lipoplatin Formulation Review Article
2011
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
2018 Standout
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
2009
Lipoplatin Treatment in Lung and Breast Cancer
2010
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
Analysis of nanoparticle delivery to tumours
2016 Standout
Short‐chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling
2019
Nanoparticle formulations of cisplatin for cancer therapy
2016
Works of Sofia Lampaki being referenced
Use of Proteins as Biomarkers and Their Role in Carcinogenesis
2014
Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer
2009
mTOR pathway: A current, up-to-date mini-review (Review)
2014
Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin [MVAC] versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer.
2011
Stem cells’ guided gene therapy of cancer: New frontier in personalized and targeted therapy
2014